Elite Pharmaceuticals, Inc. (ELTP) Operating income 2017–2026
Elite Pharmaceuticals, Inc. (ELTP) annual operating income history from SEC filings — each fiscal year as reported.
$49.1MFY2026 · since FY2017: -$7.4M → $49.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $49.1M | +150.6% |
| FY2025 | $19.6M | +81.7% |
| FY2024 | $10.8M | +193.5% |
| FY2023 | $3.7M | -27.5% |
| FY2022 | $5.1M | +140.9% |
| FY2021 | $2.1M | +192.1% |
| FY2020 | -$2.3M | +75.0% |
| FY2019 | -$9.2M | -1.2% |
| FY2018 | -$9.1M | -23.0% |
| FY2017 | -$7.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice